De farmakokinetiske resultater viste, at systemisk eksponering var lavere end hos voksne med pulmonal hypertension (se pkt.
The pharmacokinetic findings showed that systemic exposure was lower than in adults with pulmonary hypertension (see section 5.2) which may provide